Cargando…

The prognostic impact of RAS on overall survival following liver resection in early versus late-onset colorectal cancer patients

BACKGROUND: The impact of molecular aberrations on survival after resection of colorectal liver metastases (CLM) in patients with early-age-onset (EOCRC) versus late-age-onset colorectal cancer (LOCRC) is unknown. METHODS: Patients who underwent liver resection for CLM with known RAS, BRAF and MSI s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jácome, Alexandre A., Vreeland, Timothy J., Johnson, Benny, Kawaguchi, Yoshikuni, Wei, Steven H., Nancy You, Y., Vilar, Eduardo, Vauthey, Jean-Nicolas, Eng, Cathy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884678/ https://www.ncbi.nlm.nih.gov/pubmed/33208919 http://dx.doi.org/10.1038/s41416-020-01169-w

Ejemplares similares

Minimal Residual Disease in Colorectal Cancer: Are We Finding the Needle in a Haystack?
por: Jácome, Alexandre A., et al.
Publicado: (2023)

The role of systemic chemotherapy and multidisciplinary management in improving the overall survival of patients with metastatic squamous cell carcinoma of the anal canal
por: Eng, Cathy, et al.
Publicado: (2014)

Surgical Margins during Hepatic Surgery for Colorectal Liver Metastases: Complete Resection not Millimeters Defines Outcome
por: Pawlik, Timothy M., et al.
Publicado: (2007)

Resectability and resection rates of colorectal liver metastases according to RAS and BRAF mutational status: prospective study
por: Uutela, Aki, et al.
Publicado: (2022)

The impact of sarcopenia on overall survival in patients with pan-RAS wild-type colorectal liver metastasis receiving hepatectomy
por: Yang, Yao-Ren, et al.
Publicado: (2023)

Surgical Resection or Radiofrequency Ablation for Small Hepatocellular Carcinoma
por: Kawaguchi, Yoshikuni, et al.
Publicado: (2023)

Surgery for colorectal liver metastases: the impact of resection margins on recurrence and overall survival
por: Angelsen, Jon-Helge, et al.
Publicado: (2014)

Associations of smoking with early- and late-onset colorectal cancer
por: Li, Hengjing, et al.
Publicado: (2023)

LATE IMPACT OF THE LAPAROSCOPIC TREATMENT OF DEEP INFILTRATING ENDOMETRIOSIS WITH SEGMENTAL COLORECTAL RESECTION
por: ROCHA, Antonio Matos, et al.
Publicado: (2018)

BRAF and RAS mutations as prognostic factors in metastatic colorectal cancer patients undergoing liver resection
por: Schirripa, M, et al.
Publicado: (2015)

Prognostic assessment of resected colorectal liver metastases integrating pathological features, RAS mutation and Immunoscore
por: Baldin, Pamela, et al.
Publicado: (2020)

Extended RAS analysis and correlation with overall survival in advanced pancreatic cancer
por: Haas, Michael, et al.
Publicado: (2017)

Extended RAS Analysis of the Phase III EPIC Trial: Irinotecan + Cetuximab Versus Irinotecan as Second‐Line Treatment for Patients with Metastatic Colorectal Cancer
por: Sobrero, Alberto, et al.
Publicado: (2020)

Overall Survival in Phase 3 Clinical Trials and the Surveillance, Epidemiology, and End Results Database in Patients With Metastatic Colorectal Cancer, 1986-2016: A Systematic Review
por: Shen, Chan, et al.
Publicado: (2022)

Embryologic Origin of the Primary Tumor and RAS Status Predict Survival after Resection of Colorectal Liver Metastases
por: Alexandrescu, Sorin Tiberiu, et al.
Publicado: (2022)

Preoperative chemotherapy prior to pulmonary metastasectomy in surgically resected primary colorectal carcinoma
por: Subbiah, Ishwaria M., et al.
Publicado: (2014)

Intermediate-onset colorectal cancer: A clinical and familial boundary between both early and late-onset colorectal cancer
por: Arriba, María, et al.
Publicado: (2019)

Exploratory pooled analysis evaluating the effect of sequence of biological therapies on overall survival in patients with RAS wild-type metastatic colorectal carcinoma
por: Peeters, Marc, et al.
Publicado: (2018)

Circulating inflammation signature predicts overall survival and relapse-free survival in metastatic colorectal cancer
por: Varkaris, Andreas, et al.
Publicado: (2019)

Does primary tumor resection contribute to overall survival in unresectable synchronous metastatic colorectal cancer?
por: Ergun, Yakup, et al.
Publicado: (2020)

Targeting BRAF and RAS in Colorectal Cancer
por: Bellio, Helene, et al.
Publicado: (2021)

Survival improvement for patients with metastatic colorectal cancer over twenty years
por: Zeineddine, Fadl A., et al.
Publicado: (2023)

Ras signaling in aging and metabolic regulation
por: Slack, Cathy
Publicado: (2017)

Implications of RAS Mutations on Oncological Outcomes of Surgical Resection and Thermal Ablation Techniques in the Treatment of Colorectal Liver Metastases
por: Rhaiem, Rami, et al.
Publicado: (2022)

Resectability, conversion, metastasectomy and outcome according to RAS and BRAF status for metastatic colorectal cancer in the prospective RAXO study
por: Uutela, Aki, et al.
Publicado: (2022)

Akt-mediated Ephexin1–Ras interaction promotes oncogenic Ras signaling and colorectal and lung cancer cell proliferation
por: Kim, Jeeho, et al.
Publicado: (2021)

Targeting RAS Mutant Colorectal Cancer with Dual Inhibition of MEK and CDK4/6
por: Sorokin, Alexey V., et al.
Publicado: (2022)

Probe-based confocal laser endomicroscopy for real-time evaluation of colorectal liver metastasis in resected surgical specimens
por: Takao, Mikiya, et al.
Publicado: (2023)

The reality of early-onset colorectal cancer: highlighting the needs in a unique but emerging population
por: Rogers, Jane E., et al.
Publicado: (2021)

Artificial intelligence quantified tumour-stroma ratio is an independent predictor for overall survival in resectable colorectal cancer
por: Zhao, Ke, et al.
Publicado: (2020)

Monitoring of RAS mutant clones in plasma of patients with RAS mutant metastatic colorectal cancer
por: Fernández Montes, A., et al.
Publicado: (2022)

Clinicopathological factors associated with recurrence in patients undergoing resection of pancreatic solid pseudopapillary neoplasm
por: Paredes, Oscar, et al.
Publicado: (2021)

Differential clinicopathological and molecular features within late-onset colorectal cancer according to tumor location
por: Brandariz, Lorena, et al.
Publicado: (2018)

Hepatic Metastasectomy in Squamous Cell Carcinoma of the Anal Canal: A Case Series of a Curative Approach
por: Rogers, Jane E., et al.
Publicado: (2023)

Tumorigenicity of RTK/RAS in urothelium
por: Wu, Xue-Ru, et al.
Publicado: (2015)

The Presence of Mutations in the K-RAS Gene Does Not Affect Survival after Resection of Pulmonary Metastases from Colorectal Cancer
por: Zabaleta, Jon, et al.
Publicado: (2014)

Late, late-onset infections in the nursery.
por: Baltimore, R. S.
Publicado: (1988)

MUTYH Mutations Do Not Cause HNPCC or Late Onset Familial Colorectal Cancer
por: Stormorken, Astrid, et al.
Publicado: (2006)

Late-Onset Acute Liver Injury From Azathioprine
por: Schwartz, Benjamin, et al.
Publicado: (2022)

Late-onset peritoneal recurrence of advanced gastric cancer 20 years after primary resection
por: Okugawa, Yoshinaga, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_l4qc7utjjdc1v60b4mg6rqih45